MXCT vs PAYX · rev $38.6M vs P/E 22, rev $5.57B
MaxCyte Inc (MXCT) versus Paychex Inc (PAYX) — a side-by-side from cached financials, not a winner call.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
Paychex Inc (PAYX) is a software - application company listed on NASDAQ.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
Latest reported PAYX revenue for 2025-05-31 was $5.57B. Net income was $1.66B. Revenue was up 5.6% from 2024-05-31 to 2025-05-31. PAYX currently screens at market cap $34.96B and trailing P/E 21.5.
MXCT currently screens at market cap $124.3M. PAYX currently screens at market cap $34.96B and trailing P/E 21.5.
Not investment advice. Open the MXCT and PAYX stock pages for the full models.
Not investment advice.